Literature DB >> 21389603

Streptavidin-aequorin fusion protein for bioluminescent immunoassay.

Satoshi Inouye1, Jun-ichi Sato, Satoko Sasaki, Yuiko Sahara.   

Abstract

The fusion protein of streptavidin to aequorin (STA-AQ) was highly purified from inclusion bodies in Escherichia coli cells and applied to a bioluminescent sandwich immunoassay. α-Fetoprotein (AFP), which is a serological marker of liver cancer, was used as a model analyte to test STA-AQ in an immunoassay. The measurable range of AFP by the sandwich immunoassay, using the complex of STA-AQ and the biotinylated anti-AFP antibody, was 0.02-200 ng/mL with an average coefficient of variation of 4.9%. The detection sensitivity with the complex of STA-AQ and the biotinylated anti-AFP antibody was similar to that with the complex of biotinylated aequorin, streptavidin and the biotinylated anti-AFP antibody. STA-AQ would be a useful reporter protein for immunoassays.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389603     DOI: 10.1271/bbb.100798

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Facile Synthesis and Characterization of a Novel Tamavidin-Luciferase Reporter Fusion Protein for Universal Signaling Applications.

Authors:  David B Broyles; Emre Dikici; Sylvia Daunert; Sapna K Deo
Journal:  Adv Biosyst       Date:  2020-02-28

2.  Chromophore attachment to fusion protein of streptavidin and recombinant allophycocyanin α subunit.

Authors:  Jing Wu; Huaxin Chen; Peng Jiang
Journal:  Bioengineered       Date:  2017-05-19       Impact factor: 3.269

Review 3.  Coelenterazine-Dependent Luciferases as a Powerful Analytical Tool for Research and Biomedical Applications.

Authors:  Vasilisa V Krasitskaya; Eugenia E Bashmakova; Ludmila A Frank
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.